LMR GEORGETTE PMHNP BOARD EXAM REVIEW ACTUAL
2026/2027 - COMPLETE QUESTIONS WITH DETAILED RATIONALES
100% VERIFIED ANSWERS - PASS GUARANTEED - A+ GRADED
190 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Differentiate nuanced presentations of psychiatric disorders across the lifespan
2 Select and manage psychopharmacologic regimens based on pharmacogenomics, drug interactions, and
comorbidities
3 Apply ethical, legal, and safety frameworks in complex clinical situations
4 LMR Georgette PMHNP Board Exam Review Actual 2026
5 2027
6 Complete Questions with Detailed Rationales 100% Verified Answers
7 Pass Guaranteed
8 A+ Graded
9 Foundations of Psychiatric-Mental Health Nurse Practitioner
10 Applied Psychiatric-Mental Health Nurse Practitioner
11 Advanced Psychiatric-Mental Health Nurse Practitioner
12 Psychiatric-Mental Health Nurse Practitioner Review
Page 1
,Q1 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
A patient with treatment-resistant depression has failed two adequate SSRI trials.
Pharmacogenomic testing reveals CYP2D6 poor metabolizer phenotype and a
5-HTTLPR short/short genotype. Which augmentation strategy is most likely to be
both effective and safe?
A. Add bupropion, a CYP2D6 inhibitor, to the current SSRI.
B. Switch to a serotonin-norepinephrine reuptake inhibitor that is not CYP2D6 dependent.
CORRECT
C. Add a tricyclic antidepressant at a standard dose.
D. Start a monoamine oxidase inhibitor without a washout period.
RATIONALE: A CYP2D6 poor metabolizer should avoid medications heavily reliant on this
enzyme; switching to an SNRI like venlafaxine (less CYP2D6 dependent) is safer. Bupropion
inhibits CYP2D6, increasing SSRI levels. TCAs are CYP2D6 substrates, risking toxicity. MAOIs
require a washout to prevent serotonin syndrome.
Q2 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
A patient presents with acute onset of confusion, agitation, visual hallucinations,
fever, and myoclonus 5 days after starting a serotonergic antidepressant. Which
intervention is most critical in the initial management?
A. Administer propranolol to control tachycardia.
B. Discontinue the serotonergic agent and administer cyproheptadine. CORRECT
C. Increase the antidepressant dose to overcome tolerance.
D. Start a typical antipsychotic for hallucinations.
RATIONALE: This presentation is consistent with serotonin syndrome. The cornerstone of
management is stopping the serotonergic agent and providing supportive care; cyproheptadine is
a serotonin antagonist used in moderate cases. Propranolol may worsen hypotension.
Antipsychotics can exacerbate hyperthermia and lower seizure threshold.
Page 2
,Q3 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
A patient with bipolar I disorder is stabilized on lithium. Routine labs show a
serum creatinine of 1.4 mg/dL (baseline 0.9). Which adjustment is most
appropriate to prevent nephrotoxicity?
A. Discontinue lithium and start valproate immediately.
B. Reduce lithium dose and recheck renal function in 1 week. CORRECT
C. Continue current dose and monitor creatinine every 6 months.
D. Encourage high sodium intake to protect renal function.
RATIONALE: Rising creatinine indicates potential lithium nephrotoxicity; dose reduction and
closer monitoring are warranted. Abrupt discontinuation risks relapse. Continuing the same dose
risks further damage. High sodium can lower lithium levels but does not protect the kidneys.
Q4 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
Which of the following best distinguishes delirium from dementia in a hospitalized
patient?
A. Delirium has an insidious onset, while dementia is acute.
B. Delirium is characterized by fluctuating consciousness, while dementia typically has clear
sensorium. CORRECT
C. Dementia is always reversible, while delirium is permanent.
D. Delirium primarily affects memory, while dementia affects attention.
RATIONALE: The hallmark of delirium is acute onset and fluctuating level of consciousness,
whereas dementia usually presents with clear consciousness and progressive cognitive decline.
Option A is reversed. Option C is false-delirium is often reversible. Option D mischaracterizes the
primary deficits.
Page 3
, Q5 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
A patient with generalized anxiety disorder is started on buspirone. Which
statement accurately describes its pharmacological profile?
A. It acts as a full agonist at GABA-A receptors, producing immediate anxiolysis.
B. It is a 5-HT1A receptor partial agonist with a delayed onset of 2-4 weeks. CORRECT
C. It potentiates the effects of alcohol and benzodiazepines.
D. It carries a high risk of physical dependence and withdrawal.
RATIONALE: Buspirone is a partial agonist at 5-HT1A receptors and requires 2-4 weeks for full
therapeutic effect. It does not act on GABA-A, does not potentiate alcohol or benzodiazepines,
and has no abuse liability or withdrawal syndrome.
Q6 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
A patient with schizophrenia has persistent negative symptoms despite adequate
antipsychotic treatment. Which agent is most likely to improve negative symptoms
without worsening metabolic side effects?
A. Olanzapine
B. Clozapine
C. Cariprazine CORRECT
D. Haloperidol
RATIONALE: Cariprazine is a partial D3/D2 agonist that has shown efficacy for negative
symptoms with a lower metabolic burden compared to olanzapine and clozapine. Haloperidol is
primarily positive symptoms and can worsen negative symptoms via D2 blockade.
Page 4
2026/2027 - COMPLETE QUESTIONS WITH DETAILED RATIONALES
100% VERIFIED ANSWERS - PASS GUARANTEED - A+ GRADED
190 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Differentiate nuanced presentations of psychiatric disorders across the lifespan
2 Select and manage psychopharmacologic regimens based on pharmacogenomics, drug interactions, and
comorbidities
3 Apply ethical, legal, and safety frameworks in complex clinical situations
4 LMR Georgette PMHNP Board Exam Review Actual 2026
5 2027
6 Complete Questions with Detailed Rationales 100% Verified Answers
7 Pass Guaranteed
8 A+ Graded
9 Foundations of Psychiatric-Mental Health Nurse Practitioner
10 Applied Psychiatric-Mental Health Nurse Practitioner
11 Advanced Psychiatric-Mental Health Nurse Practitioner
12 Psychiatric-Mental Health Nurse Practitioner Review
Page 1
,Q1 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
A patient with treatment-resistant depression has failed two adequate SSRI trials.
Pharmacogenomic testing reveals CYP2D6 poor metabolizer phenotype and a
5-HTTLPR short/short genotype. Which augmentation strategy is most likely to be
both effective and safe?
A. Add bupropion, a CYP2D6 inhibitor, to the current SSRI.
B. Switch to a serotonin-norepinephrine reuptake inhibitor that is not CYP2D6 dependent.
CORRECT
C. Add a tricyclic antidepressant at a standard dose.
D. Start a monoamine oxidase inhibitor without a washout period.
RATIONALE: A CYP2D6 poor metabolizer should avoid medications heavily reliant on this
enzyme; switching to an SNRI like venlafaxine (less CYP2D6 dependent) is safer. Bupropion
inhibits CYP2D6, increasing SSRI levels. TCAs are CYP2D6 substrates, risking toxicity. MAOIs
require a washout to prevent serotonin syndrome.
Q2 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
A patient presents with acute onset of confusion, agitation, visual hallucinations,
fever, and myoclonus 5 days after starting a serotonergic antidepressant. Which
intervention is most critical in the initial management?
A. Administer propranolol to control tachycardia.
B. Discontinue the serotonergic agent and administer cyproheptadine. CORRECT
C. Increase the antidepressant dose to overcome tolerance.
D. Start a typical antipsychotic for hallucinations.
RATIONALE: This presentation is consistent with serotonin syndrome. The cornerstone of
management is stopping the serotonergic agent and providing supportive care; cyproheptadine is
a serotonin antagonist used in moderate cases. Propranolol may worsen hypotension.
Antipsychotics can exacerbate hyperthermia and lower seizure threshold.
Page 2
,Q3 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
A patient with bipolar I disorder is stabilized on lithium. Routine labs show a
serum creatinine of 1.4 mg/dL (baseline 0.9). Which adjustment is most
appropriate to prevent nephrotoxicity?
A. Discontinue lithium and start valproate immediately.
B. Reduce lithium dose and recheck renal function in 1 week. CORRECT
C. Continue current dose and monitor creatinine every 6 months.
D. Encourage high sodium intake to protect renal function.
RATIONALE: Rising creatinine indicates potential lithium nephrotoxicity; dose reduction and
closer monitoring are warranted. Abrupt discontinuation risks relapse. Continuing the same dose
risks further damage. High sodium can lower lithium levels but does not protect the kidneys.
Q4 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
Which of the following best distinguishes delirium from dementia in a hospitalized
patient?
A. Delirium has an insidious onset, while dementia is acute.
B. Delirium is characterized by fluctuating consciousness, while dementia typically has clear
sensorium. CORRECT
C. Dementia is always reversible, while delirium is permanent.
D. Delirium primarily affects memory, while dementia affects attention.
RATIONALE: The hallmark of delirium is acute onset and fluctuating level of consciousness,
whereas dementia usually presents with clear consciousness and progressive cognitive decline.
Option A is reversed. Option C is false-delirium is often reversible. Option D mischaracterizes the
primary deficits.
Page 3
, Q5 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
A patient with generalized anxiety disorder is started on buspirone. Which
statement accurately describes its pharmacological profile?
A. It acts as a full agonist at GABA-A receptors, producing immediate anxiolysis.
B. It is a 5-HT1A receptor partial agonist with a delayed onset of 2-4 weeks. CORRECT
C. It potentiates the effects of alcohol and benzodiazepines.
D. It carries a high risk of physical dependence and withdrawal.
RATIONALE: Buspirone is a partial agonist at 5-HT1A receptors and requires 2-4 weeks for full
therapeutic effect. It does not act on GABA-A, does not potentiate alcohol or benzodiazepines,
and has no abuse liability or withdrawal syndrome.
Q6 DIFFERENTIATE NUANCED PRESENTATIONS OF PSYCHIATRIC DISORDERS ACROSS
THE LIFESPAN
A patient with schizophrenia has persistent negative symptoms despite adequate
antipsychotic treatment. Which agent is most likely to improve negative symptoms
without worsening metabolic side effects?
A. Olanzapine
B. Clozapine
C. Cariprazine CORRECT
D. Haloperidol
RATIONALE: Cariprazine is a partial D3/D2 agonist that has shown efficacy for negative
symptoms with a lower metabolic burden compared to olanzapine and clozapine. Haloperidol is
primarily positive symptoms and can worsen negative symptoms via D2 blockade.
Page 4
